Atıf Formatları
New perspective for the treatment of Alzheimer diseases: Liposomal rivastigmine formulations
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

N. M. KARAKAŞ Et Al. , "New perspective for the treatment of Alzheimer diseases: Liposomal rivastigmine formulations," Drug Development and Industrial Pharmacy , vol.37, no.7, pp.775-789, 2011

KARAKAŞ, N. M. Et Al. 2011. New perspective for the treatment of Alzheimer diseases: Liposomal rivastigmine formulations. Drug Development and Industrial Pharmacy , vol.37, no.7 , 775-789.

KARAKAŞ, N. M., Deǧim, Z., Yilmaz, Ş., Eiz, D., & Nacar, A., (2011). New perspective for the treatment of Alzheimer diseases: Liposomal rivastigmine formulations. Drug Development and Industrial Pharmacy , vol.37, no.7, 775-789.

KARAKAŞ, NAZMİ Et Al. "New perspective for the treatment of Alzheimer diseases: Liposomal rivastigmine formulations," Drug Development and Industrial Pharmacy , vol.37, no.7, 775-789, 2011

KARAKAŞ, NAZMİ M. Et Al. "New perspective for the treatment of Alzheimer diseases: Liposomal rivastigmine formulations." Drug Development and Industrial Pharmacy , vol.37, no.7, pp.775-789, 2011

KARAKAŞ, N. M. Et Al. (2011) . "New perspective for the treatment of Alzheimer diseases: Liposomal rivastigmine formulations." Drug Development and Industrial Pharmacy , vol.37, no.7, pp.775-789.

@article{article, author={NAZMİ MUTLU KARAKAŞ Et Al. }, title={New perspective for the treatment of Alzheimer diseases: Liposomal rivastigmine formulations}, journal={Drug Development and Industrial Pharmacy}, year=2011, pages={775-789} }